Product

4D-310

2 clinical trials

1 indication

Indication
Fabry Disease
Clinical trial
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease
Status: Active (not recruiting), Estimated PCD: 2026-01-01
Clinical trial
An Open-Label, Phase 1/2a Trial of Gene Therapy 4D-310 in Adults With Fabry Disease and Cardiac Involvement
Status: Active (not recruiting), Estimated PCD: 2026-01-01